uniQure (QURE)
(Delayed Data from NSDQ)
$13.49 USD
-0.51 (-3.64%)
Updated Aug 6, 2025 04:00 PM ET
After-Market: $13.37 -0.12 (-0.89%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth A Momentum D VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
QURE 13.49 -0.51(-3.64%)
Will QURE be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for QURE based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for QURE
Wall Street Analysts Think uniQure (QURE) Could Surge 142.67%: Read This Before Placing a Bet
uniQure (QURE) Reports Q2 Loss, Misses Revenue Estimates
QURE: What are Zacks experts saying now?
Zacks Private Portfolio Services
3 Top Genomics Stocks to Add to Your Portfolio in 2025
Wall Street Analysts See a 161.51% Upside in uniQure (QURE): Can the Stock Really Move This High?
UniQure (QURE) Reports Q1 Loss, Misses Revenue Estimates
Other News for QURE
Franklin Biotechnology Discovery Fund Q2 2025 Commentary
Biotech stocks rise following Prasad exit from FDA
Biotech stocks rise following Prasad exit from FDA
uniQure (QURE) Price Target Trimmed by Cantor Fitzgerald
uniQure price target lowered by $11 at Cantor Fitzgerald, here's why